Prekallikrein human deficient plasma (acquired)

Frozen

Packaging options

6-PPDPKA	Vial	Minimum 50 mL

Description of the Prekallikrein human deficient plasma (acquired)

Packaging in bottle. The minimum packaged volume is 50 mL. The price offer is based on the volume requested.

Advantages

Minimize test time.
Ready to use.

Informations

Prekallikrein is a glycoprotein, a serine protease zymogen. Non-covalently complexed with high molecular weight kininogen.
Prekallikrein participates in the activation of coagulation, fibrinolysis, the generation of kinins and inflammatory phenomena. It is activated to kallikrein by FXIIa.

product sheet

Price list, safety data sheets and notices are accessible to our registered customers.

Focus on

	These kits are manufactured in accordance with the 98/79 EC directive for in vitro diagnostic devices. Only CE marked products can be used for diagnostic applications in Europe.
	These kits are intended for in vitro diagnostic use.
	These kits are for research use only and are not intended to be used for diagnostic procedures.
	Federal Drug Administration, FDA validates diagnostic kits for in vitro diagnostic use in the United States.
	Biological risk products.
	Storage between 2 and 8 ° C.
	Stability after opening at 2-8 ° C.
	Products that can be refrozen.
	Stability 12 months after refreezing at -20 ° C.
	Manufacturer.
	Importer
	Distributor.

My personal Space

Nouveau client

Prekallikrein human deficient plasma (acquired)

Price list, safety data sheets and notices are accessible to our registered customers.

My personal Space

Nouveau client

Prekallikrein human deficient plasma (acquired)

Price list, safety data sheets and notices are accessible to our registered customers.

Associated products

Human Prekallikrein congenital Deficient Plasma